CCMB, Aganitha to apply Generative AI for therapeutic design, research
The Centre for Cellular & Molecular Biology (CCMB) and Aganitha, a new generation 'in silico' solutions provider, signed a framework agreement to apply Generative Artificial Intelligence (AI) solutions for designing novel therapeutics and ...